Market Context — Why This Technology, Why Now

Global regulatory bodies are tightening indoor air quality standards, pushing industries from healthcare to food processing to adopt advanced microbial control. Consumer demand for safer, healthier environments in public and private spaces is also surging. This technology meets these evolving needs by providing a chemical-free, energy-efficient solution that can be seamlessly integrated into existing infrastructure, offering a competitive edge to businesses prioritizing public health and operational sustainability.

Key Competitive Advantages
01

Combines Compact Design with High Efficiency: Reduces installation space by ~1/3 while increasing microbial inactivation efficiency by 1.5x compared to conventional large-scale systems.

02

Increases Virus Adsorption by 2x: Precisely controlled activated carbon pore sizes (80-120nm) enhance virus adsorption by up to 2x compared to existing technologies, ensuring effective removal.

03

Simplifies Maintenance: Detachable activated carbon cartridges from the UV irradiation unit streamline replacement, potentially reducing maintenance time by 30%.

Market Opportunity
Healthcare & Eldercare Facilities
$300M–$400M globally (AI est.)
Strengthening infection control in healthcare settings is a critical challenge, driving continuous demand for high-efficiency microbial inactivation devices. The compact size facilitates easy integration into limited spaces like patient rooms and waiting areas.
Hospital system integrators Medical device manufacturers Eldercare facility solution providers
Food Processing Plants
$150M–$250M globally (AI est.)
Stricter food safety standards necessitate rigorous airborne microbial control in production lines and storage areas. This chemical-free technology supports safe and efficient environmental maintenance.
Food processing equipment OEMs Industrial air purification providers Food safety technology developers
Office & Commercial Buildings
$200M–$300M globally (AI est.)
Demand is increasing for HVAC system integration and individual air purification solutions to protect employee and customer health. This technology is ideal for spaces requiring compact, discreet installation.
HVAC system manufacturers Commercial air purifier brands Smart building technology providers
Public Transportation
$50M–$100M globally (AI est.)
Infection control is crucial in enclosed, high-occupancy spaces like buses, trains, and aircraft. Its compact size allows for easy integration into existing HVAC systems, enhancing passenger confidence.
Automotive and aerospace suppliers Public transit system operators Cabin air quality solution providers
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a microbial inactivation system featuring precisely pore-controlled activated carbon (80-120nm diameter) combined with UV irradiation, specifically covering a detachable cartridge structure. The claims were granted after successfully overcoming two office actions, indicating a robust and difficult-to-invalidate scope of protection.

Competitive White Space

This patent focuses on the core inactivation mechanism. White space exists in integrating advanced IoT monitoring for real-time pathogen detection, developing AI-driven predictive maintenance for cartridge replacement, or optimizing for specific industrial gas streams beyond air purification.

Economic Impact
~$150K/year estimated operational cost savings per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Implementing this technology in healthcare facilities and food processing plants could reduce chemical usage by ~40% (saving ~$35K/year (AI est.)), decrease filter replacement frequency by 20% (saving ~$65K/year (AI est.)), and optimize capital expenditure through space savings and reduced maintenance labor (saving ~$65K/year (AI est.)), leading to total estimated annual operational cost savings of ~$165K per facility (AI est.).

Speed to Market
6× faster than in-house development
Developing similar technology in-house from scratch, including optimizing pore-controlled activated carbon, integrating UV irradiation, and miniaturization design, is estimated to take approximately 3 years. By licensing this patent, which has established basic principles and secured IP rights, significant time can be saved in the design phase. Focusing on integration into existing products or prototype development could shorten time-to-market to approximately 0.5 years, enabling rapid business expansion.
Competitive Positioning

X: Cost Efficiency
Y: Hygiene Improvement Level

Business Models & Applications
📦 Product Sales Model
This model involves directly manufacturing and selling microbial inactivation cartridges and devices incorporating this technology. Developing specialized product lines for healthcare, food, and public facilities could capture high-value market segments.
🤝 Technology Licensing Model
This model involves licensing the patented technology to air purifier manufacturers, HVAC system providers, or medical device companies. It leverages licensee development resources for broad product integration and royalty revenue generation.
🔄 Subscription Service Model
This service model combines device rental with regular cartridge replacement and maintenance. It offers continuous revenue and a stable hygienic environment for customers seeking to minimize initial deployment costs.
Adjacent Application Opportunities
💧 Water Treatment & Purification
Application in Drinking Water & Wastewater Systems
This technology's combination of pore-controlled activated carbon and UV irradiation is applicable to inactivating microbes in water. Integrating it into household water purifiers or industrial wastewater treatment systems could contribute to safe water supply and reduce environmental impact by up to 30%.
🍎 Food Freshness Preservation
Freshness Preservation for Food Storage & Transport
Inactivating airborne microbes within food storage facilities and transport containers could suppress spoilage and extend food freshness for longer periods, potentially reducing food waste by 15-20% and improving supply chain efficiency.
🏡 Home Appliances
Next-Generation Air Purifiers & Humidifiers
Leveraging its compact size, this technology could be integrated into home air purifiers, humidifiers, or robotic vacuums. This could lead to products that efficiently remove viruses and allergens, improving indoor air quality by over 50% and providing safer, more comfortable living spaces.
Integration Roadmap — Estimated 16-Month Deployment
Phase 1: Technology Validation & Prototype Development
Duration: 4 months
Optimize the pore-controlled activated carbon and UV irradiation modules, and conduct basic design for miniaturization. Verify integration feasibility into existing airflow systems and build a functional prototype.
Phase 2: Product Development & Field Testing
Duration: 8 months
Based on the prototype, proceed with mass production design tailored to the licensee's specific product requirements. Conduct field tests in target environments like healthcare facilities and food processing plants to evaluate and improve performance and durability.
Phase 3: Mass Production & Market Launch
Duration: 4 months
Establish a mass production system for the final product, incorporating test results, and confirm compliance with relevant regulations. Officially release the product to the market and build sales channels to initiate full-scale business operations.
Technical Feasibility
This technology features a detachable activated carbon cartridge from the UV irradiation unit, offering high modular independence and relatively easy integration into existing HVAC systems or air purification devices. The pore-controlled activated carbon can be produced using existing manufacturing techniques, and the UV irradiation unit is based on general-purpose UV lamp technology, indicating high feasibility for adoption with minimal new capital investment.
Success Scenario
Implementing this technology could reduce hospital-acquired infection risks by 30% in healthcare facilities. This may lead to shorter patient stays and reduced burden on medical staff, potentially resulting in hundreds of thousands of dollars in annual cost savings and improved patient satisfaction. In food processing plants, the risk of microbial contamination in products could be significantly reduced, preventing issues like product recalls and potentially avoiding millions of dollars in annual losses while protecting brand value.
Patent Record
APPLICATION NO.
特願2022-133776
REGISTRATION NO.
7267653
FILING DATE
2022/08/25
GRANT DATE
2023/04/24
EXPIRATION DATE
2042/08/25
PATENT HOLDER
大学共同利用機関法人自然科学研究機構
Examination History
2022年08月29日
早期審査に関する事情説明書
2022年08月29日
出願審査請求書
2022年09月28日
早期審査に関する通知書
2022年11月16日
拒絶理由通知書
2022年12月20日
意見書
2022年12月20日
手続補正書（自発・内容）
2023年02月08日
拒絶理由通知書
2023年02月20日
手続補正書（自発・内容）
2023年02月20日
意見書
2023年04月05日
特許査定